Accession Number: | 0000899243-19-012936 |
Date: | 2019-05-07 |
Issuer: | AMEDISYS INC (AMED) |
Original Submission Date: |
KEMMERLY DAVID L
3854 AMERICAN WAY, SUITE A
BATON ROUGE, LA 70816
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-05-07 | M | 5,000 | a | $27.35 | 27,524 | direct | ||
COMMON STOCK | 2019-05-07 | S | 4,900 | d | $118.18 | 22,624 | direct | ||
COMMON STOCK | 2019-05-07 | S | 100 | d | $119.32 | 22,524 | direct | ||
COMMON STOCK | 2019-05-07 | 0 | $0.00 | 445 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 27.35 | 2019-05-07 | deemed execution date | M | 5,000 (d) | 2025-05-01 | common stock 5,000 | $27.35 | 32,500 | direct |
ID | footnote |
---|---|
f1 | the total amount of shares beneficially owned includes 219 shares held in an employee stock purchase plan account. |
f2 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $118.00 to $118.92, inclusive. the reporting person undertakes to provide to amedisys, inc. (the "issuer"), any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this form 4. |
f3 | the information in this report is based on a plan statement dated as of march 31, 2019. |
f4 | on may 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. the options are subject to time-based vesting conditions. 18,750 of the options vested on may 1, 2019, and the remaining 18,750 options will vest on may 1, 2020, provided that the reporting person remains continuously employed by the issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the options. |